dabigatran (Pradaxa)

DRUG2 trials

Sponsors

Bayer

Conditions

Atrial Fibrillation

Unknown Phase

Real-world Comparative Effectiveness of Dabigatran Versus Vitamin K Antagonist

CompletedNCT02687867

BayerAtrial Fibrillation

Start: 2016-02-12End: 2016-03-01Updated: 2017-04-05

Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France

CompletedNCT02864758

BayerAtrial Fibrillation

Start: 2016-09-08End: 2018-09-30Updated: 2023-11-07

Related Papers

Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study

EP Europace2019-10-0122 citations